Salasani, Indah Lady .
HRN: 18-05-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 750MG (VIAL)
10/02/2022
10/09/2022
IVT
275mg
Q8
AGE; URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes